3D Osteoimmune Stem Cell Spheroids with Osteoinduction and Immunomodulation Dual Functionality for In Vivo Bone Tissue Engineering
Source abstract
Abstract
Effective bone regeneration requires not only robust osteoinduction but also precise immunomodulation to orchestrate the complex healing process. In this study, we present a strategy for engineering multifunctional three-dimensional (3D) stem cell spheroids (Sphe-BP-IL4-BMP2) by integrating black phosphorus (BP) nanosheets coloaded with interleukin-4 (IL-4) together with recombinant human bone morphogenetic protein-2 (rhBMP-2). BP nanosheets served as a biodegradable scaffold and a delivery vehicle, enabling sustained release of rhBMP-2 and IL-4 to enhance osteogenic differentiation and to promote anti-inflammatory M2 macrophage polarization, respectively. The resulting spheroids exhibited a well-defined morphology, enhanced cell viability, and uniform BP nanosheet distribution. The in vitro studies demonstrated Sphe-BP-IL4-BMP2 has significantly upregulated osteogenic markers and ALP activity alongside potent immunomodulatory effects on macrophages. Further in vivo implantation into a rat calvarial defect model led to increased angiogenesis and accelerated bone regeneration without adverse effects. The results highlight the therapeutic synergy between osteoinductive and immunomodulatory cues within a 3D spheroid platform, offering a promising avenue for treating critical-sized bone defects.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Mesenchymal stem cell research · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Physiology and Biomedical Engineering
Mayo Clinic
Department of Orthopedic Surgery
Department of Neurologic Surgery
Funding
National Institutes of Health
References (66)
Show source-provided references
1. 10.1038/s44222-024-00269-z10.1038/s44222-024-00269-z ↗
2. 10.1111/j.1601-0825.2010.01682.x10.1111/j.1601-0825.2010.01682.x ↗
3. 10.1016/j.dental.2011.11.02510.1016/j.dental.2011.11.025 ↗
4. 10.1097/BOT.000000000000142010.1097/BOT.0000000000001420 ↗
5. 10.1016/j.biomaterials.2019.11936610.1016/j.biomaterials.2019.119366 ↗
6. 10.1016/j.tibtech.2012.07.00510.1016/j.tibtech.2012.07.005 ↗
7. Amini, A. R.; Laurencin, C. T.; Nukavarapu, S. P. Bone Tissue Engineering: Recent Advances and Challenges Crit. Rev. Biomed. Eng. 2012; Vol. 40 5, 363−40810.1615/CritRevBiomedEng.v40.i5.10.10.1615/CritRevBiomedEng.v40.i5.10 ↗
8. 10.1302/2046-3758.73.BJR-2017-0270.R110.1302/2046-3758.73.BJR-2017-0270.R1 ↗
9. 10.1038/s41578-020-0204-210.1038/s41578-020-0204-2 ↗
10. Sheehy E. · 2018 · 12710.1016/B978-0-08-100803-4.00005-X ↗
11. 10.1021/acsnano.0c0398110.1021/acsnano.0c03981 ↗
12. 10.1089/ten.teb.2011.025110.1089/ten.teb.2011.0251 ↗
13. 10.1007/s10439-014-1104-710.1007/s10439-014-1104-7 ↗
14. 10.1089/ten.tea.2011.029410.1089/ten.tea.2011.0294 ↗
15. 10.1002/adma.20080200910.1002/adma.200802009 ↗
16. 10.1002/adhm.20200034910.1002/adhm.202000349 ↗
17. 10.1021/acsabm.4c0100110.1021/acsabm.4c01001 ↗
18. 10.1038/s44222-024-00213-110.1038/s44222-024-00213-1 ↗
19. 10.1016/j.biomaterials.2021.12101410.1016/j.biomaterials.2021.121014 ↗
20. 10.1021/acs.biomac.9b0013310.1021/acs.biomac.9b00133 ↗
21. 10.1021/acsbiomaterials.6b0060710.1021/acsbiomaterials.6b00607 ↗
22. 10.1021/acsbiomaterials.1c0130410.1021/acsbiomaterials.1c01304 ↗
23. 10.1038/natrevmats.2016.4010.1038/natrevmats.2016.40 ↗
24. 10.1016/j.bioactmat.2022.03.03910.1016/j.bioactmat.2022.03.039 ↗
25. 10.1016/j.addr.2010.02.00310.1016/j.addr.2010.02.003 ↗
26. 10.1038/nrrheum.2009.22810.1038/nrrheum.2009.228 ↗
27. 10.1093/stcltm/szab03010.1093/stcltm/szab030 ↗
28. 10.1016/j.tibtech.2018.01.00510.1016/j.tibtech.2018.01.005 ↗
29. 10.1007/s12015-020-10006-910.1007/s12015-020-10006-9 ↗
30. 10.1016/j.tibtech.2016.08.00410.1016/j.tibtech.2016.08.004 ↗
31. 10.1155/2016/917635710.1155/2016/9176357 ↗
32. 10.1186/s12896-014-0105-910.1186/s12896-014-0105-9 ↗
33. 10.1021/acsnano.1c0968810.1021/acsnano.1c09688 ↗
34. 10.1111/j.1582-4934.2008.00516.x10.1111/j.1582-4934.2008.00516.x ↗
35. 10.21037/sci.2019.06.0410.21037/sci.2019.06.04 ↗
36. 10.1007/s00441-020-03191-z10.1007/s00441-020-03191-z ↗
37. 10.1007/s12015-015-9640-610.1007/s12015-015-9640-6 ↗
38. 10.1007/s12015-020-09979-410.1007/s12015-020-09979-4 ↗
39. 10.1016/j.actbio.2022.09.05210.1016/j.actbio.2022.09.052 ↗
40. 10.1007/s40820-021-00697-110.1007/s40820-021-00697-1 ↗
41. 10.1039/D0BM01972K10.1039/D0BM01972K ↗
42. 10.1021/acs.chemrev.9b0044510.1021/acs.chemrev.9b00445 ↗
43. 10.1002/adfm.20180830610.1002/adfm.201808306 ↗
44. 10.1039/D4CS00007B10.1039/D4CS00007B ↗
45. 10.1002/adhm.20230377210.1002/adhm.202303772 ↗
46. 10.1039/D0BM01728K10.1039/D0BM01728K ↗
47. 10.1002/1097-4636(200101)54:13.0.CO;2-D10.1002/1097-4636(200101)54:13.0.CO;2-D ↗
48. 10.1089/ten.tea.2007.022910.1089/ten.tea.2007.0229 ↗
49. 10.1007/s10439-009-9841-810.1007/s10439-009-9841-8 ↗
50. 10.1016/j.tice.2023.10211210.1016/j.tice.2023.102112 ↗
51. 10.1093/intimm/dxy05410.1093/intimm/dxy054 ↗
52. 10.1016/j.immuni.2016.02.01510.1016/j.immuni.2016.02.015 ↗
53. 10.1002/jcp.2642910.1002/jcp.26429 ↗
54. 10.1016/j.pharmthera.2024.10876010.1016/j.pharmthera.2024.108760 ↗
55. 10.1016/j.bioactmat.2023.03.02110.1016/j.bioactmat.2023.03.021 ↗
56. 10.1016/j.biomaterials.2023.12209510.1016/j.biomaterials.2023.122095 ↗
57. 10.1016/j.biomaterials.2022.12160410.1016/j.biomaterials.2022.121604 ↗
58. 10.1002/adma.20150367810.1002/adma.201503678 ↗
59. 10.1021/jacs.5b0602510.1021/jacs.5b06025 ↗
60. 10.1038/s41419-017-0126-010.1038/s41419-017-0126-0 ↗
61. 10.1002/jbm.a.3527810.1002/jbm.a.35278 ↗
62. 10.1038/s41598-023-46237-210.1038/s41598-023-46237-2 ↗
63. 10.1016/j.msec.2020.11181210.1016/j.msec.2020.111812 ↗
64. 10.1089/ten.tea.2019.019010.1089/ten.tea.2019.0190 ↗
65. 10.1016/j.biomaterials.2014.10.01710.1016/j.biomaterials.2014.10.017 ↗
66. 10.1089/ten.tea.2020.004110.1089/ten.tea.2020.0041 ↗